Brief: MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
05/11/2025 12:40
Nov 5 (Reuters) - MoonLake Immunotherapeutics MLTX.O: MOONLAKE IMMUNOTHERAPEUTICS ANNOUNCES PRICING OF $75 MILLION UNDERWRITTEN OFFERING MOONLAKE IMMUNOTHERAPEUTICS - PRICES 7.1 MILLION CLASS A ORDINARY SHARES AT $10.50 EACH Source text: ID:nGNX8w9Hv7 Further company coverage: MLTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial